MX21453A - Preparaciones farmaceuticas que se administran en forma topica. - Google Patents

Preparaciones farmaceuticas que se administran en forma topica.

Info

Publication number
MX21453A
MX21453A MX2145390A MX2145390A MX21453A MX 21453 A MX21453 A MX 21453A MX 2145390 A MX2145390 A MX 2145390A MX 2145390 A MX2145390 A MX 2145390A MX 21453 A MX21453 A MX 21453A
Authority
MX
Mexico
Prior art keywords
pharmaceutical preparations
topically administered
topically
administered
preparations
Prior art date
Application number
MX2145390A
Other languages
English (en)
Inventor
Pier Giorgio Ferrini
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX21453A publication Critical patent/MX21453A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2145390A 1989-07-07 1990-06-04 Preparaciones farmaceuticas que se administran en forma topica. MX21453A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH279589 1989-07-07

Publications (1)

Publication Number Publication Date
MX21453A true MX21453A (es) 1994-01-31

Family

ID=4241754

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2145390A MX21453A (es) 1989-07-07 1990-06-04 Preparaciones farmaceuticas que se administran en forma topica.

Country Status (13)

Country Link
EP (1) EP0407345A3 (es)
JP (1) JPH0344396A (es)
KR (1) KR910002451A (es)
AU (1) AU638034B2 (es)
CA (1) CA2020563A1 (es)
DD (1) DD300353A5 (es)
FI (1) FI903328A7 (es)
HU (1) HU206267B (es)
IE (1) IE902482A1 (es)
MX (1) MX21453A (es)
NZ (1) NZ234378A (es)
PT (1) PT94610A (es)
ZA (1) ZA905310B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
KR100732454B1 (ko) * 2001-08-31 2007-06-27 재단법인 포항산업과학연구원 고온 엑스선 실험용 고온장치
US20080182822A1 (en) * 2006-11-17 2008-07-31 Besins Healthcare Sa Liquid Pharmaceutical Compositions Comprising a Bisphosphonate Compound
EP1923049A1 (en) * 2006-11-17 2008-05-21 Besins Healthcare Pharmaceutical compositions comprising a bisphosphonate compound
EP2833721B1 (en) * 2012-03-14 2021-02-17 Novan Inc. Nitric oxide releasing pharmaceutical compositions
BR112016002387B1 (pt) 2013-08-08 2019-05-21 Novan, Inc. Composições farmacêuticas tópicas, e método para seu armazenamento
CN105813617B (zh) 2014-08-08 2021-05-28 诺万公司 局部用组合物和使用所述组合物的方法
EP3423100A4 (en) 2016-03-02 2019-10-16 Novan, Inc. COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION AND METHOD FOR THE TREATMENT THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
GB8618259D0 (en) * 1986-07-25 1986-09-03 Leo Pharm Prod Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
CA2020563A1 (en) 1991-01-08
IE902482A1 (en) 1991-02-13
ZA905310B (en) 1991-03-27
JPH0344396A (ja) 1991-02-26
AU638034B2 (en) 1993-06-17
KR910002451A (ko) 1991-02-25
NZ234378A (en) 1992-08-26
FI903328A7 (fi) 1991-01-08
HUT54503A (en) 1991-03-28
EP0407345A2 (de) 1991-01-09
HU206267B (en) 1992-10-28
AU5870090A (en) 1991-01-10
PT94610A (pt) 1991-03-20
DD300353A5 (de) 1992-06-04
EP0407345A3 (en) 1991-07-24
HU904127D0 (en) 1990-12-28
FI903328A0 (fi) 1990-07-02

Similar Documents

Publication Publication Date Title
MX21452A (es) Preparaciones farmaceuticas que se administran en forma topica.
FI924340L (fi) Farmaceutiska beredningar
FI912952L (fi) Kontrollerbart frigoerande farmaceutiskt preparat.
NL194578B (nl) Farmaceutisch preparaat met cyclosporine.
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
DK0539319T3 (da) Farmaceutisk cyclosporinpræparat
DK360988A (da) Farmaceutiske cyclodextrinholdige praeparater
FI930836A7 (fi) Syklosporiinia sisältäviä paikallisia valmisteita
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
IT1215291B (it) Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.
FI873630A7 (fi) Stabilt farmaceutiskt preparat.
FI872808A7 (fi) Uudet tooppisesti annostettavat farmaseuttiset koostumukset, joilla on systeeminen vaikutus.
FI964285L (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
FI852804A7 (fi) Säädellysti vapauttavia farmaseuttisia valmisteita.
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
FI893643L (fi) Farmaceutiska kompositioner.
FI913100A7 (fi) Farmaseuttiset valmisteet
DE3682960D1 (de) Pharmazeutische praeparate.
FI883673A7 (fi) Farmaceutiska kompositioner.
DE3576118D1 (de) Pharmazeutische praeparate.
MX21453A (es) Preparaciones farmaceuticas que se administran en forma topica.
FI874382L (fi) Farmaceutiska preparat.
NO883609L (no) Farmasoeytiske preparater for topisk anvendelse.
FI923371A0 (fi) En farmaceutisk formulation.
DE3866789D1 (de) Pharmazeutische zusammensetzungen.